847445-81-2 = 486460-32-6 + 898543-70-9 反应条件:1.1 Reagents: Hydrogen Catalysts: Di-μ-Chlorobis[(1,2,5,6-η)-1,5-Cyclooctadiene]Dirhodium,Ammonium Chloride,(2R)-1-[(1R)-1-[bis(1,1-Dimethylethyl)Phosphino]Ethyl]-2-(Diphenylphosphino)Ferr... Solvents: Methanol; 16 H,115 Psi,50 °C 标题:Identification Of Ammonium Chloride As An Effective Promoter Of The Asymmetric Hydrogenation Of A β-Enamine Amide 作者:Clausen,Andrew M.; Dziadul,Brianne; Cappuccio,Kristine L.; Kaba,Mahmoud; Starbuck,Cindy; Et Al 参考文献:Organic Process Research & Development 日期:2006 卷标:10(4) 页码:723-726
专利号:US-2024035023-A1 优先权日:2022-06-24 标题 :Computer implemented method for engineering fluorinase enzymes for synthesis of fluorophenyl compounds 发明人:R PRAVIN KUMAR; G GLADSTONE SIGAMANI; L ROOPA; B K NAVEEN; SHETTY ANUJ J; M LIKITH 权利人:KCAT ENZYMATIC PRIVATE LTD 摘要:The present invention discloses a computer-implemented method for engineering fluorinase enzymes towards the synthesis of fluorophenyl compounds. Limited or no mechanistic details of fluorinase enzymes have hindered progress in understanding their catalytic mechanisms for synthesizing synthetic organofluorine compounds. Through a comprehensive computational screening process, specific methionine-sulfonium phenyl substrates, including [(3S)-3-amino-3-carboxypropyl][2,5-difluoro-4-(4-methoxy-2,4-dioxobutyl)phenyl]methylsulfonium, were designed and optimized using quantum chemical optimization techniques. This methodology uncovers crucial information on F— ion attack conformation and the catalytic mechanism of the substrate, leading to the formation of Methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate. Furthermore, a protein sequence and 3D modeling-based enzyme screening process was employed to identify the most suitable enzyme for this substrate. The identified enzyme was then engineered using the mechanistic insights gained from the studies, resulting in improved substrate scope, stability and catalytic efficiency. This computer-based approach offers an efficient and precise alternative to traditional trial-and-error methods, advancing the field towards the successful synthesis fluorophenyl compounds.
专利号:US-11459549-B2 优先权日:2018-05-10 标 题:Method for biocatalytic synthesis of Sitagliptin and intermediate thereof 发明人:WU FAHAO; YANG WEN; LI GANG; SHI HONGWEI; GAO YANGZHE; LIU LILI; YUAN ZHIFA 权利人:CHINA FORTUNE WAY COMPANY; NANJING REDWOOD FINE CHEMICAL CO LTD 摘要:Provided is a method for biocatalytic synthesis of Sitagliptin and intermediates thereof, in particular, provided are compounds of Formula (I) and Formula (II), or pharmaceutically acceptable salts thereof, a polypeptide capable of catalyzing conversion of a compound of Formula (I) to a compound of Formula (II), a nucleic acid encoding the polypeptide, a vector and a cell comprising the nucleic acid. In addition, also provided are a method for producing a compound of Formula (II) and Sitagliptin by using the polypeptide and the compound of Formula (I), and a method for preparing the polypeptide.
专利号:US-10787458-B2 优先权日:2014-09-25 标 题:Chiral synthesis of N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-A]pyrazines 发明人:HOVEYDA HAMID; DUTHEUIL GUILLAUME 权利人:OGEDA SA 摘要:Disclosed is a novel chiral synthesis of N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines of Formula (I): n nor a solvate thereof. The novel chiral synthesis avoids the use of protection/deprotection steps.
专利号:WO-2023021529-A1 优先权日:2021-08-17 标题:Improved enzymatic synthesis of sitagliptin or its salts thereof 发明人:DATLA ANUPAMA; NAGRE PRASHANT; TAMORE JAGDISH; WADHAVANE SACHIN; MURALIDHARAN KRISHNA; TRIVIKRAM SREENATH 权利人:FERMENTA BIOTECH LTD 摘要:The present invention discloses an improved enzymatic synthesis of Sitalgiptin or its pharmaceutically acceptable salts in good yield and purity. The present invention provides novel intermediate (R)- 3-Acetamido-4-(2,4,5-Trifluorophenyl) butanoic acid (5).
专利号:US-2022274917-A1 优先权日:2019-09-06 标题 :Solvent free continuous process for the synthesis of metformin hyrochloride 发明人:KULKARNI AMOL ARVIND; SHARMA BRIJESH 权利人:COUNCIL SCIENT IND RES 摘要:The present invention provides a continuous solvent free and additive free process for the synthesis of Metformin Hydrochloride in a screw reactor. >90% conversion of the solid substrates without solvent is obtained in a screw reactor to produce Metformin Hydrochloride with at least 90% selectivity.
专利号:US-10005720-B2 优先权日:2013-04-05 标题:Compounds useful for the treatment of metabolic disorders and synthesis of the same 发明人:SEXTON JONATHAN Z; BRENMAN JAY E; MUSSO DAVID L 权利人:NORTH CAROLINA CENTRAL UNIV; UNIV NORTH CAROLINA CHAPEL HILL 摘要:The present invention provides compounds of Formula (I): wherein variables X, Y, Z and R1 are as described herein. Some of the compounds described herein are glutamate dehydrogenase activators. The invention is also directed to pharmaceutical compositions comprising these compounds, uses of these compounds and compositions in the treatment of metabolic disorders as well as synthesis of the compounds.
1: Zeng DK, Xiao Q, Li FQ, Tang YZ, Jia CL, Tang XW. Cardiovascular risk of sitagliptin in treating patients with type 2 diabetes mellitus. Biosci Rep. 2019 Jul 15;39(7):BSR20190980. doi: 10.1042/BSR20190980. 2: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. Sitagliptin. 2019 Feb 7. 2018:6091014. doi: 10.1155/2018/6091014.
合成参考文献
参考文献:10.1097/mpa.0b013e318214832d 摘要:Kim YS, Oh SH, Park KS, No H, Oh BJ, Kim SK, Jung HS, Kim JH, Lee MS, Lee MK, Kim KW. Improved outcome of islet transplantation in partially pancreatectomized diabetic mice by inhibition of dipeptidyl peptidase-4 with sitagliptin. Pancreas. 2011 Aug;40(6):855–60. doi: 10.1097/mpa.0b013e318214832d. 参考文献:10.1155/2011/279530 摘要:Marathe CS, Rayner CK, Jones KL, Horowitz M. Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function. Experimental Diabetes Research. 2011;2011():1–10. doi: 10.1155/2011/279530. 参考文献:10.1155/2011/601047 摘要:Rowzee AM, Cawley NX, Chiorini JA, Di Pasquale G. Glucagon-Like Peptide-1 Gene Therapy. Experimental Diabetes Research. 2011;2011():1–5. doi: 10.1155/2011/601047. 参考文献:10.1155/2011/898913 摘要:Dicembrini I, Pala L, Rotella CM. From Theory to Clinical Practice in the Use of GLP-1 Receptor Agonists and DPP-4 Inhibitors Therapy. Experimental Diabetes Research. 2011;2011():1–8. doi: 10.1155/2011/898913. 参考文献:10.1089/dia.2011.0050 摘要:DeYoung MB, MacConell L, Sarin V, Trautmann M, Herbert P. Encapsulation of Exenatide in Poly-( d,l -Lactide-Co-Glycolide) Microspheres Produced an Investigational Long-Acting Once-Weekly Formulation for Type 2 Diabetes. Diabetes Technology & Therapeutics. 2011 Nov;13(11):1145–54. doi: 10.1089/dia.2011.0050.